These phenotypes about TGF‐β, CAFs, and CD8+ T cell were in concert with our previously described anti‐tumor effectiveness by combining ANO1 knockdown, anti‐PD‐1 immunotherapy, and ferroptosis inhibition (Figure 6L). The gene discussed is CD8A; the disease is neoplasm.